Vivos Therapeutics Inc.
Vivos Therapeutics Inc. (VVOS): 7 pipeline candidates · ~2 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
1.5 months
D/E -23.12 · 9% dilution
Lead: Approved
7 candidates
N/A
2 buys · 0 sells (180d)
A transparent, data-derived signal for Vivos Therapeutics Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$7.9M
Cash
$2.1M
Quarterly Burn
$6.0M
Runway
1.5 mo
Revenue
$5.1M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
| Drug | Phase |
|---|---|
| c.a.r.e. appliance (dna | — |
| c.a.r.e. appliance (dna | — |
| dna appliance | Approved |
| mmrna appliance | Approved |
| mrna appliance | Approved |
| versa | Approved |
| vivos vida sleep | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
21
Total value held
$2.0M
| Holder | Shares | Value |
|---|---|---|
| armistice capital, llc | 1,115,859 | $1.3M |
| vanguard capital management llc | 273,329 | $323K |
| geode capital management, llc | 95,543 | $113K |
| commonwealth equity services, llc | 42,500 | $50K |
| vanguard fiduciary trust co | 30,832 | $36K |
| blackrock, inc. | 27,817 | $33K |
| xtx topco ltd | 25,117 | $30K |
| state street corp | 24,922 | $29K |
| sequoia financial advisors, llc | 24,000 | $28K |
| acorn wealth advisors, llc | 14,776 | $17K |
Showing top 10 of 21 institutional holders of Vivos Therapeutics Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Vivos Therapeutics Inc.'s pipeline?
Vivos Therapeutics Inc. (VVOS) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Vivos Therapeutics Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Vivos Therapeutics Inc. has approximately 1.5 months of cash runway.
What is Vivos Therapeutics Inc.'s market capitalization?
Vivos Therapeutics Inc.'s market capitalization is approximately $7.9M.
Who is the CEO of Vivos Therapeutics Inc.?
Mr. R. Kirk Huntsman is the chief executive officer of Vivos Therapeutics Inc. (VVOS).
Get the full picture on Vivos Therapeutics Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.